Endocrinology, Diabetes & Metabolism Doctors in Bryn Mawr, PA Accepting Medicare

5 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 5

Margaret Ting Ryan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 360, Bryn Mawr, PA 19010 Phone: 610-527-1604    Fax: 610-525-8018

Dr. Vanita Proothi Treat, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800

Dr. Anne Depapp, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 621 Great Springs Rd, Bryn Mawr, PA 19010 Phone: 267-305-2340

Denise Joffe, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-1604    Fax: 610-525-8018

Dr. Cheryl A. Koch, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800    Fax: 610-527-0334

News Archive

Britain tests human influenza plan

The British Government's response to a human flu pandemic was tested in Exercise Winter Willow on Monday 19th and Tuesday 20th February.

Researchers identify gene variants that substantially increase risk for schizophrenia

Schizophrenia has long been known to be highly heritable and is present in approximately 1% of the population. Researchers have been following two paths in their pursuit of identifying schizophrenia risk genes.

Study suggests potential therapeutic strategy against diabetes

Maintaining vitamin D receptor levels in pancreatic cells that synthesize and secrete insulin (β cells) could contribute to protecting against the development of diabetes and counteract pancreatic cell damage caused by the progression of the disease.

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.

Read more Medical News

› Verified 7 days ago